Unassociated Document

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
  
         
   
FORM 12b-25
SEC FILE NUMBER:
000-26059
         
   
NOTIFICATION OF LATE FILING
CUSIP NUMBER:
16941P 10 2
         
(Check One):
  
x Form 10-K   o Form 20-F   o Form 11-K   o Form 10-Q   o Form 10-D   o Form N-SAR
o Form N-CSR
 
For Period Ended:
December 31, 2008
 
o
Transition Report on Form 10-K
    
 
o
Transition Report on Form 20-F
    
 
o
Transition Report on Form 11-K
    
 
o
Transition Report on Form 10-Q
    
 
o
Transition Report on Form N-SAR
    
 
For the Transition Period Ended:
  
     
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
     
If the notification relates to a portion of the filing checked above, identify the Item(s) to which notification relates:
 
     
PART I - REGISTRANT INFORMATION
 
CHINA SKY ONE MEDICAL, INC.
Full Name of Registrant
 
N/A
Former Name if Applicable
 
Room 1706, Di Wang Building, No. 30 Gan Shui Road, Nangang District
Address of Principal Executive Office (Street and Number):
 
Harbin, People’s Republic of China 150001
City, State and Zip Code
     
PART II - RULE 12b-25(b) AND (c)
     
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed.  (Check box if appropriate.)
     
 
(a)  The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
 
x
(b)  The subject annual report, semi-annual report, transition report on Form 10-K, 10-KSB, 20-F, 11-K, Form N-SAR or Form N-CSR, or portion thereof will be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
 
(c)  The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
 
 
PART III - NARRATIVE
  
     
State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
  
   
 
Our Annual Report on Form 10-K, for the fiscal year ended December 31, 2008, could not be filed within the prescribed time period, because we require additional time for compilation and review to insure adequate disclosure of certain information required to be included in the Form 10-K. We plan to file our Annual Report on Form 10-K on or before the 15th calendar day following the prescribed due date.
    
       
PART IV - OTHER INFORMATION
  
       
(1)
Name and telephone number of person to contact in regard to this notification
 
    
 
Hao Yu Bo
  
86-451-53994069 (China)
    
 
(Name)
  
(Area Code)
  
(Telephone Number)
    
       
(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed?  If the answer is no, identify report(s).
  
   
Yes x     No o
 
  
       
(3)
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
  
   
Yes o     No x
  
 
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state why a reasonable estimate of the results cannot be made.
 
  
 
 
CHINA SKY ONE MEDICAL, INC.
    
   
(Name of Registrant as Specified in Charter)
    
     
has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
  
         
Date:
April 1, 2009
  
By:
/s/ Liu Yan Qing
       
Name: Liu Yan Qing
       
Title: President and Chief Executive Officer
 
ATTENTION
 
Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).